Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis
A 75-year-old male with compensated Child-Pugh B cirrhosis initiated sofosbuvir plus simeprevir, and developed hepatic decompensation and died a few days thereafter. High exposure to simeprevir leading to hepatotoxicity most likely explained this fatal outcome. This observation, along with similar cases recently reported in the literature, should raise awareness of the potential for decompensation in patients with advanced cirrhosis treated with simeprevir.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Antiviral therapy - 21(2016), 1 vom: 04., Seite 91-2 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Soriano, Vincent [VerfasserIn] |
---|
Links: |
---|
Themen: |
9WS5RD66HZ |
---|
Anmerkungen: |
Date Completed 13.12.2016 Date Revised 21.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.3851/IMP2969 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM249648245 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM249648245 | ||
003 | DE-627 | ||
005 | 20231224154036.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3851/IMP2969 |2 doi | |
028 | 5 | 2 | |a pubmed24n0832.xml |
035 | |a (DE-627)NLM249648245 | ||
035 | |a (NLM)26042495 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Soriano, Vincent |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.12.2016 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A 75-year-old male with compensated Child-Pugh B cirrhosis initiated sofosbuvir plus simeprevir, and developed hepatic decompensation and died a few days thereafter. High exposure to simeprevir leading to hepatotoxicity most likely explained this fatal outcome. This observation, along with similar cases recently reported in the literature, should raise awareness of the potential for decompensation in patients with advanced cirrhosis treated with simeprevir | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Simeprevir |2 NLM | |
650 | 7 | |a 9WS5RD66HZ |2 NLM | |
650 | 7 | |a Sofosbuvir |2 NLM | |
650 | 7 | |a WJ6CA3ZU8B |2 NLM | |
700 | 1 | |a Barreiro, Pablo |e verfasserin |4 aut | |
700 | 1 | |a de Mendoza, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Peña, José M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antiviral therapy |d 1996 |g 21(2016), 1 vom: 04., Seite 91-2 |w (DE-627)NLM097535710 |x 2040-2058 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2016 |g number:1 |g day:04 |g pages:91-2 |
856 | 4 | 0 | |u http://dx.doi.org/10.3851/IMP2969 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2016 |e 1 |b 04 |h 91-2 |